Altamira Therapeutics所有资讯

Altamira Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Thomas Meyer(1.2%)

03/13 23:08

Altamira Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Thomas Meyer(1.3%)

2023/04/28 04:30

Altamira Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Thomas Meyer(6.3%)

2023/01/19 05:30

Altamira Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Thomas Meyer(8.0%)

2022/09/13 20:00

Altamira Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Thomas Meyer(7.4%)

2022/05/13 20:32

Altamira Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Thomas Meyer(6.3%)

2021/05/21 19:31

Altamira Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Altium Capital Management, LP EIN:(0%),Altium Growth Fund, LP EIN:(0%)等

2021/02/13 06:15

Altamira Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Thomas Meyer(5.7%)

2020/12/08 04:49

Altamira Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Thomas Meyer(9.2%)

2020/10/07 04:18

Altamira Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Thomas Meyer(8.0%)

2020/08/21 04:07

Altamira Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Altium Capital Management, LP EIN:(9.9%),Altium Growth Fund, LP EIN:(9.9%)等

2020/02/15 05:58

Altamira Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Thomas Meyer(15.4%)

2019/08/12 20:00

Altamira Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Thomas Meyer(14.4%)

2019/06/14 04:26

Altamira Therapeutics | SC 13G：超过5%持股股东披露文件-Altium Capital Management, LP EIN:(9.9%),Altium Growth Fund, LP EIN:(9.9%)等

2019/05/24 05:02

Altamira Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Rosalind Advisors, Inc.(1.2%),Steven Salamon(1.2%)等

2019/02/15 07:43

Altamira Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Sofinnova Capital VII FCPR (“SC VII”) EIN:(0.88%),Sofinnova Partners SAS, a French corporation (“SP SAS”)(0.88%)等

2019/02/15 01:02

Altamira Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Thomas Meyer(27.1%)

2018/11/22 05:27

Altamira Therapeutics | SC 13G：超过5%持股股东披露文件-Rosalind Advisors, Inc.(8.3%),Steven Salamon(8.3%)等

2018/08/11 02:55

Altamira Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Morgan Stanley(1.0%),Morgan Stanley Capital Services LLC(1.0%)

2018/08/10 04:30

Altamira Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Thomas Meyer(24.4%)

2018/07/24 04:35